Get the Stockscreener App
240.48
1.33%
3.04
Insulet Corporation stock is traded at $240.48, with a volume of 149.36K.
It is up +1.33% in the last 24 hours and up +4.63% over the past month.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.
See More
Previous Close:
$237.44
Open:
$236.89
24h Volume:
149.36K
Relative Volume:
0.24
Market Cap:
$16.77B
Revenue:
$1.87B
Net Income/Loss:
$395.30M
P/E Ratio:
140.63
EPS:
1.71
Net Cash Flow:
$182.40M
1W Performance:
+3.54%
1M Performance:
+4.63%
6M Performance:
+37.93%
1Y Performance:
+47.98%
1-Day Range:
$233.47
$240.59
1-Week Range:
$227.03
$240.78
52-Week Range:
$151.56
$243.98
Insulet Corporation Stock (PODD) Company Profile
Name
Insulet Corporation
Sector
Industry
Phone
978-600-7000
Address
100 NAGOG PARK, ACTON, MA
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-02-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-21-23 | Upgrade | Citigroup | Neutral → Buy |
| Aug-21-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-01-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-19-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Jul-28-20 | Initiated | Wells Fargo | Overweight |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-03-20 | Initiated | BofA/Merrill | Neutral |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Dec-10-19 | Initiated | CFRA | Sell |
| Oct-23-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-14-19 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-04-19 | Downgrade | UBS | Buy → Neutral |
| Oct-03-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-06-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-10-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| May-06-19 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Feb-22-18 | Reiterated | Barclays | Overweight |
| Jan-08-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-03-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-15-17 | Initiated | Barclays | Overweight |
View All
Insulet Corporation Stock (PODD) Latest News
iPhone App Now Available for Omnipod 5 Users - Healthnews.com
Insulet Stock Gains From Expansion Strategies, Innovation - Barchart
Stay Ahead of the Game With Insulet (PODD) Q3 Earnings: Wall Street's Insights on Key Metrics - Yahoo Finance
(PODD) On The My Stocks Page - Stock Traders Daily
Symmetry Partners LLC Invests $924,000 in Insulet Co. (NASDAQ:PODD) - MarketBeat
Jury To Decide Timing Issue In Insulin Patch Trade Secret Row - Law360
Insulet Trade Secrets Claims Duck Time-Bar Challenge for Now - Bloomberg Law
Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November - StockTitan
Congress Asset Management Co. Grows Stock Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet (PODD) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Insulet Co. (NASDAQ:PODD) Shares Sold by abrdn plc - MarketBeat
Insulet (PODD) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
Insulet rolls out iPhone app for Omnipod 5 insulin pump in US - Yahoo Finance
AMI Asset Management Corp Sells 108,677 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Co. (NASDAQ:PODD) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
10 Best Growth Stocks Of October 2024 - Forbes
Omnipod® 5 App for iPhone® Now Fully Available in the United States - Business Wire
Integrated Advisors Network LLC Acquires 34,128 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Mediolanum International Funds Ltd Sells 26,197 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
ProPicks AI Top-10 Countdown: 2 Short-Term Power Plays Yielding Massive 40%+ Gains - Investing.com
Insulet Insiders Sold US$7.0m Of Shares Suggesting Hesitancy - Simply Wall St
Insulet Co. (NASDAQ:PODD) Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Is Insulet Stock a Smart Addition to Your Portfolio Right Now? - MSN
Trend Tracker for (PODD) - Stock Traders Daily
Insulet's Quarterly Earnings Preview: What You Need to Know - MSN
Insulet to expand with 110 new jobs in Mass., as Watertown life sciences firm looks to add 20 - Worcester Business Journal
PAHC vs. PODD: Which Stock Is the Better Value Option? - Yahoo Finance
Profitable S&P 500 Stocks to Buy in a Strong Q4: NVIDIA & 2 Others - Yahoo Finance
Insulet's Quarterly Earnings Preview: What You Need To Know - Barchart
Insulet Co. (NASDAQ:PODD) Shares Purchased by Chicago Capital LLC - MarketBeat
Equities Analysts Offer Predictions for Insulet Q3 Earnings - MarketBeat
Leerink Partnrs Brokers Lift Earnings Estimates for Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet price target raised to $260 from $250 at BTIG - Yahoo Finance
Market Participants Recognise Insulet Corporation's (NASDAQ:PODD) Revenues - Simply Wall St
Insulet (NASDAQ:PODD) Price Target Raised to $260.00 at BTIG Research - MarketBeat
Ayrshire Capital Management LLC Invests $3.98 Million in Insulet Co. (NASDAQ:PODD) - MarketBeat
Is Insulet Corporation (NASDAQ:PODD) The Top Stock With Improving Technical Ratings According To Piper Sandler? - Yahoo Finance
National Campaign Launches to Combat Diabetes Stigma Using Comedy - Marketscreener.com
Diversified Trust Co Sells 6,033 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Corp (PODD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance - Yahoo Finance
Here’s Why ClearBridge Growth Strategy Increased its Position in Insulet Corporation (PODD) - Insider Monkey
Azzad Asset Management Inc. ADV Makes New Investment in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Co. (NASDAQ:PODD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
HLN or PODD: Which Is the Better Value Stock Right Now? - Yahoo Finance
Is There Now An Opportunity In Insulet Corporation (NASDAQ:PODD)? - Simply Wall St
Dimensional Fund Advisors LP Increases Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet (NASDAQ:PODD) Price Target Raised to $275.00 at Citigroup - MarketBeat
Fidelity Growth Strategies Fund Trimmed Insulet Corporation (PODD) to Manage the Position Size - Insider Monkey
Sei Investments Co. Has $5.91 Million Stake in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024 - BioSpace
Insulet's SWOT analysis: diabetes tech firm's stock poised for growth - Investing.com
Insulet Corporation Stock (PODD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):